The 9th China Maternal and Child Health Andrology Conference was successfully held in Shandong.
Date:2025-09-22 Redact:WBL

1.jpg


From September 19 to 21, 2025, the 9th China Maternal and Child Health Andrology Conference and the 2025 Academic Conference of the Andrology Branch of the Chinese Society of Sexual Medicine, organized by the Chinese Society of Sexual Medicine and the Andrology Branch of the Chinese Society of Sexual Medicine, and hosted by Shandong Provincial Maternal and Child Health Hospital, successfully took place in Jinan, Shandong. As an important academic exchange platform in the field of maternal and child health andrology, the conference gathered experts and scholars in the industry to discuss cutting-edge topics in the field, providing guidance for clinical diagnosis, treatment practices, and technological innovations.


2.jpg


Focus on Erectile Dysfunction Diagnosis and Treatment


5.jpg


3.jpg


4.jpg


Dr. Liu Lei, Deputy Director of the Urology Department at the First People's Hospital of Zunyi, shared the "R+L Diagnostic and Therapeutic System for Erectile Dysfunction (ED)" at the conference. She systematically reviewed the characteristics of ED and the current clinical diagnosis and treatment situation, focusing on the clinical application and research results of Low-Intensity Pulsed Ultrasound (LIPUS) technology, offering a safer and more effective treatment option for ED patients.


WBL LIPUS Technology Principles and Treatment Effects


1744964764395344.png


The core mechanism of WBL LIPUS is the use of low-energy pulsed ultrasound (acoustic intensity range: 50-350 mW/cm²) applied to the penile cavernous tissue. This activates endogenous stem cells, promotes the regeneration of blood vessels and nerves, and repairs damaged vascular endothelium and nerve matrix, thereby improving erectile function from a pathological level. Compared to traditional oral medications (such as PDE5 inhibitors), penile prosthesis implantation, or invasive therapies (such as cavernous injection), WBL LIPUS is a safe, non-invasive treatment that does not lead to drug dependency, side effects, or surgical complications.


1744964785859804.jpg


Competitive Advantages of WBL LIPUS


1744964860395019.jpg


Non-invasiveness and Safety

No need for drugs or surgery, avoiding liver and kidney burden and infection risks, especially suitable for patients with chronic conditions (such as diabetes).  


Comprehensive Treatment Model

The unique “LIPUS + Psychological Counseling + VR” multidimensional treatment combines physiological repair with psychological intervention, resulting in a 30% increase in patient satisfaction.  


Clinical Data Support

With clinical validation from over 60 global medical institutions, its efficacy and safety have been endorsed by authoritative institutions such as UCSF and Peking University Hospital.


1738830000299863.png


This conference marks a leap in ED treatment from “symptom control” to “function regeneration.” The popularization and application of LIPUS technology provide a safer and more efficient solution for male health management. As Dr. Liu Lei stated, “Technology empowers medicine, allowing ED patients to regain confidence and dignity.”


Back